MAPK and JAK/STAT pathways targeted by miR-23a and miR-23b in prostate cancer: computational and in vitro approaches. (Q38918320)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25604141%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

title

MAPK and JAK/STAT pathways targeted by miR-23a and miR-23b in prostate cancer: computational and in vitro approaches (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25604141%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

1 reference

Seyed Hamid Aghaee Bakhtiari

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25604141%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Mahmood Naderi

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25604141%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Pezhman Fard-Esfahani

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25604141%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Reza Mahdian

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25604141%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

9

Masoud Soleimani

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25604141%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

author name string

Ehsan Arefian

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25604141%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Farshid Noorbakhsh

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25604141%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Vahideh Nodouzi

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25604141%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Mojgan Asgari

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25604141%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

publication date

22 January 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25604141%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25604141%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

volume

36

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25604141%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25604141%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

page(s)

4203-4212

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25604141%20AND%20SRC:MED&resulttype=core&format=json

International variation in prostate cancer incidence and mortality rates.

28 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3057-3

Drug development for metastatic castration-resistant prostate cancer: current status and future perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3057-3

MicroRNAs: target recognition and regulatory functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3057-3

Gene silencing by microRNAs: contributions of translational repression and mRNA decay

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3057-3

The therapeutic potential of microRNAs in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3057-3

Miravirsen (SPC3649) can inhibit the biogenesis of miR-122.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3057-3

Developing therapeutic microRNAs for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3057-3

miR-34 - a microRNA replacement therapy is headed to the clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3057-3

MicroRNA miR-548d is a superior regulator in pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3057-3

MicroRNA target prediction and validation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3057-3

TarBase 6.0: capturing the exponential growth of miRNA targets with experimental support

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3057-3

Evaluation of online miRNA resources for biomedical applications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3057-3

Dissecting Major Signaling Pathways throughout the Development of Prostate Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3057-3

Signal integration by JNK and p38 MAPK pathways in cancer development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3057-3

p38 MAPK in development and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3057-3

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3057-3

Androgen metabolism and JAK/STAT pathway genes and prostate cancer risk.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3057-3

Correlation analysis of JAK-STAT pathway components on prognosis of patients with prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3057-3

Genomic Analysis Highlights the Role of the JAK-STAT Signaling in the Anti-proliferative Effects of Dietary Flavonoid-'Ashwagandha' in Prostate Cancer Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3057-3

DIANA miRPath v.2.0: investigating the combinatorial effect of microRNAs in pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3057-3

Development of a robust, low cost stem-loop real-time quantification PCR technique for miRNA expression analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3057-3

The Promise of MicroRNA Replacement Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3057-3

The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3057-3

RNA interference-directed knockdown of urokinase plasminogen activator and urokinase plasminogen activator receptor inhibits prostate cancer cell invasion, survival, and tumorigenicity in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3057-3

Comprehensive microRNA Profiling of Prostate Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3057-3

miR-23b represses proto-oncogene Src kinase and functions as methylation-silenced tumor suppressor with diagnostic and prognostic significance in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3057-3

The altered expression of MiR-221/-222 and MiR-23b/-27b is associated with the development of human castration resistant prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3057-3

Interleukin-6 and prostate cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3057-3

Interleukin-6 regulation of prostate cancer cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3057-3

Inhibition of tumor growth and sensitization to chemotherapy by RNA interference targeting interleukin-6 in the androgen-independent human prostate cancer PC3 model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3057-3

MicroRNA-23a promotes the growth of gastric adenocarcinoma cell line MGC803 and downregulates interleukin-6 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3057-3

MicroRNAs and prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3057-3

miRNApath: a database of miRNAs, target genes and metabolic pathways.

21 January 2018

1 reference

12 December 2020

mimiRNA: a microRNA expression profiler and classification resource designed to identify functional correlations between microRNAs and their targets

1 reference

12 December 2020

Targeting AKT/mTOR and ERK MAPK signaling inhibits hormone-refractory prostate cancer in a preclinical mouse model

1 reference

12 December 2020

Activation of mitogen-activated protein kinase associated with prostate cancer progression.

1 reference

12 December 2020

Reproducible and Reliable Real-time PCR Assay to Measure Mature Form of miR-141.

1 reference

12 December 2020

10.1007/S13277-015-3057-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25604141%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

28 February 2020

1006465965

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25604141%20AND%20SRC:MED&resulttype=core&format=json